NCT00700661View on ClinicalTrials.gov

A Study of MK0476 in the Treatment of Asthma Patients Aged 2-5 Years (0476-907)

PHASE3CompletedINTERVENTIONAL
Enrollment

500

Participants

Timeline

Start Date

January 31, 2001

Primary Completion Date

December 31, 2002

Study Completion Date

December 31, 2002

Conditions
Asthma
Interventions
DRUG

montelukast

One montelukast 4-mg chewable tablet (CT) administered once daily at bedtime. Duration of Treatment: 48 Weeks

DRUG

placebo (unspecified)

Matching-image Montelukast placebo. Duration of Treatment: 48 Weeks

All Listed Sponsors
lead

Organon and Co

INDUSTRY

NCT00700661 - A Study of MK0476 in the Treatment of Asthma Patients Aged 2-5 Years (0476-907) | Biotech Hunter | Biotech Hunter